Profile data is unavailable for this security.
About the company
SpectraCure AB (publ) is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in cancer treatment technology. The Company develops photodynamic therapeutics based on photosensitive materials activated by laser. The Company's method is called interstitial photodynamic therapy (PDT). Interstitial PDT can be used for solid tumors in internal organs, such as cancer in the prostate, pancreas, and the head and neck area, among others. In addition, the Company offers software platform IDOSE for interstitial PDT treatment of solid cancer tumors in internal organs. With SpectraCure’s interstitial PDT method, the patient is given a photoactivated drug - photosensitizer in combination with laser light guided by a dose control system.
- Revenue in SEK (TTM)1.42m
- Net income in SEK-53.17m
- Incorporated2003
- Employees13.00
- LocationSpectraCure AB (publ)Gasverksgatan 1LUND 222 29SwedenSWE
- Phone+46 462863770
- Websitehttps://spectracure.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SensoDetect AB | 1.31m | -9.49m | 28.74m | 2.00 | -- | 1.78 | -- | 21.87 | -0.0249 | -0.0249 | 0.0033 | 0.0366 | 0.0944 | -11.78 | 1,314.00 | 657,000.00 | -68.15 | -- | -79.20 | -- | 160.50 | -- | -722.22 | -- | 2.60 | -315.33 | 0.00 | -- | 375.00 | -- | -17.81 | -- | -- | -- |
| Invent Medic Sweden AB | 7.70m | -6.55m | 29.08m | 7.00 | -- | 4.48 | -- | 3.78 | -0.0574 | -0.0574 | 0.0677 | 0.0587 | 0.757 | 2.96 | 4.25 | 962,928.80 | -64.32 | -93.16 | -140.86 | -121.28 | 77.71 | 77.38 | -84.97 | -305.62 | 1.07 | -4.70 | 0.1265 | -- | 9.51 | 63.94 | 10.32 | -- | -7.72 | -- |
| Qlife Holding AB | 290.00k | -6.28m | 32.14m | 5.00 | -- | -- | -- | 110.84 | -0.4088 | -3.03 | 0.0351 | -0.336 | 0.023 | 5.09 | 30.53 | 290,000.00 | -49.72 | -61.64 | -103.82 | -89.60 | -4,222.41 | -36.54 | -2,166.55 | -444.40 | 0.5089 | -- | 2.61 | -- | -79.51 | -- | 76.60 | -- | -- | -- |
| Codelab Capital AS | -92.34bn | -92.34bn | 33.64m | 28.00 | -- | 1.12 | -- | -- | -- | -- | -- | 2.25 | -- | -- | -- | -- | -- | -10.24 | -- | -11.34 | -- | 83.77 | -- | -64.81 | -- | -- | 0.00 | -- | -99.58 | -70.67 | -602.25 | -- | -22.77 | -- |
| Perpetua Medical AB (publ) | 13.57m | 3.96m | 34.23m | 11.00 | 4.57 | 4.58 | 6.32 | 2.52 | 0.8754 | 0.8754 | 3.00 | 0.8731 | 0.4046 | 13.04 | 3.87 | 4,522,697.00 | 11.65 | -71.55 | 19.36 | -91.64 | 4.34 | -49.08 | 28.80 | -180.67 | 2.28 | 8.72 | 0.4216 | -- | -30.16 | 26.04 | 86.47 | -- | -32.00 | -- |
| Miris Holding AB (publ) | 19.52m | -3.93m | 42.50m | 9.00 | -- | 1.97 | -- | 2.18 | -8.82 | -8.82 | 34.34 | 16.18 | 0.7033 | 1.00 | 4.79 | 1,952,100.00 | -14.15 | -49.33 | -20.65 | -97.47 | 85.03 | 90.68 | -20.12 | -74.98 | 2.20 | -3.02 | 0.00 | -- | 13.56 | 8.35 | 53.96 | -- | 8.55 | -- |
| SpectraCure AB (publ) | 1.42m | -53.17m | 54.31m | 13.00 | -- | 0.3906 | -- | 38.19 | -0.165 | -0.165 | 0.0052 | 0.2468 | 0.012 | -- | 1.90 | 109,384.60 | -44.68 | -13.14 | -49.10 | -14.07 | 835.02 | 243.69 | -3,739.03 | -592.49 | -- | -197.29 | 0.0325 | -- | -46.15 | -13.97 | -12.54 | -- | 0.1962 | -- |
| ScandiDos AB | 59.37m | -1.38m | 59.86m | 25.00 | -- | 1.39 | 97.02 | 1.01 | -0.0242 | -0.0242 | 1.04 | 0.7576 | 0.8416 | 1.52 | 5.60 | 2,283,539.00 | -1.96 | -8.71 | -3.04 | -14.68 | 48.30 | 52.29 | -2.33 | -10.67 | 0.7927 | -- | 0.00 | -- | 2.34 | 1.55 | 102.23 | -- | -11.62 | -- |
| Neola Medical AB | 0.00 | -10.99m | 62.36m | 8.00 | -- | 0.7948 | -- | -- | -0.1479 | -0.1479 | 0.00 | 1.01 | 0.00 | -- | -- | 0.00 | -13.81 | -15.62 | -14.65 | -16.86 | -- | 5,384.30 | -- | -6,523.93 | 5.61 | -- | 0.00 | -- | -- | -- | -11.70 | -- | 35.63 | -- |
| Kontigo Care AB | 29.11m | -1.42m | 62.92m | 10.00 | -- | 1.22 | 14.77 | 2.16 | -0.0413 | -0.0413 | 0.8385 | 1.47 | 0.4809 | -- | 6.65 | -- | -2.34 | 0.8485 | -2.94 | 1.22 | 134.25 | 127.55 | -4.87 | 1.16 | -- | -- | 0.0327 | -- | 4.45 | 11.41 | 265.57 | -- | 26.69 | -- |
| Redsense Medical AB (publ) | 30.67m | 302.00k | 64.63m | 4.00 | 196.21 | 1.80 | 109.35 | 2.11 | 0.02 | 0.02 | 1.86 | 2.18 | 0.7697 | 1.96 | 6.61 | 6,134,600.00 | 0.7578 | -14.28 | 0.8514 | -15.86 | 61.45 | 68.85 | 0.9846 | -32.79 | 4.69 | -- | 0.00 | -- | 12.85 | 16.26 | 107.58 | -- | -53.01 | -- |
| Luxbright AB | 11.06m | -18.40m | 66.12m | 12.00 | -- | 1.80 | -- | 5.98 | -0.1565 | -0.1565 | 0.0921 | 0.2819 | 0.2685 | 7.75 | 2.83 | 921,600.80 | -44.68 | -55.92 | -55.46 | -64.08 | 8.23 | -192.83 | -166.39 | -803.16 | 2.71 | -- | 0.1223 | -- | 955.60 | 66.57 | 30.18 | -- | -- | -- |
| Scandinavian ChemoTech AB | 11.68m | -8.70m | 75.71m | 1.00 | -- | 13.16 | -- | 6.48 | -0.3727 | -0.3727 | 0.5003 | 0.2653 | 0.727 | 0.5917 | 2.66 | 1,946,333.00 | -54.15 | -92.70 | -83.07 | -131.46 | 82.15 | 104.65 | -74.49 | -866.06 | 0.861 | -5.61 | 0.00 | -- | 132.67 | 63.85 | 34.96 | -- | -59.68 | -- |
Data as of Feb 06 2026. Currency figures normalised to SpectraCure AB (publ)'s reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Mar 2025 | 33.40k | 0.01% |
Data from 30 Dec 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
